3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Lung Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Brain Neoplasms
1
Interventions
Cisplatin
3
Pemetrexed
2
Etoposide
2
pomalidomide
1
etoposide phosphate
1
enzalutamide
1
bemiparin
1
apalutamide
1
alvocidib
1
abiraterone
1
Radiation
1
RRx-001
1
Gemcitabine
1
GSK2879552
1
Depsipeptides
1
Carboplatin
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Small Cell
×
RRx-001
×
Clear all
NCT03699956
2024-03-26
REPLATINUM
EpicentRx, Inc.
Phase 3
Terminated
18 enrolled